Keiji Miyoshi

发表

Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.

M. Okada, T. Sakamoto, T. Yuki, 2005, The Journal of thoracic and cardiovascular surgery.

Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.

M. Okada, T. Sakamoto, T. Yuki, 2006, The Annals of thoracic surgery.

SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.

K. Ohuchida, N. Sato, K. Mizumoto, 2010, Anticancer research.

PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor

Masafumi Nakamura, A. Fujimura, Masayo Umebayashi, 2021, Translational oncology.

Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer

K. Ohuchida, M. Onimaru, N. Sato, 2009, Cancer science.

Tumor–stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells

K. Ohuchida, K. Mizumoto, Masao Tanaka, 2009, Cancer science.

VIO soft-coagulation system for major pulmonary resections: results in 68 patients with primary lung cancer

Katsuya Nakamura, A. Uchiyama, Keiji Miyoshi, 2011, General thoracic and cardiovascular surgery.

S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.

T. Ohtsuka, Masafumi Nakamura, K. Ohuchida, 2019, International journal of oncology.

Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors

Masafumi Nakamura, Y. Oda, Katsuya Nakamura, 2022, AntiCancer Research.

Hybrid surgical approach of video-assisted minithoracotomy for lung cancer: significance of direct visualization on quality of surgery.

M. Okada, T. Sakamoto, T. Yuki, 2005, Chest.